Key result
Multi-parametric CMR provides reproducible cardiac assessment for diagnosing and monitoring cancer treatment-related cardiotoxicity.
Why the study?
Improved cancer survivorship and recognition of cardiovascular effects of cancer therapies have highlighted the need for accurate detection and monitoring of cardiotoxicity.
Population
Cancer patients at risk for or experiencing cancer treatment-related cardiotoxicity
Design
Review
Authors
Loading...
Highlights need for cardio-oncology integration in survivorship care; leaves open optimal surveillance protocols for novel therapies.
CMR provides comprehensive assessment of cardiac structure, function, and myocardial tissue characterization, making it a key imaging modality in the emerging field of cardio-oncology.
Saunderson et al. (2020) conducted a review in Cancer treatment-related cardiotoxicity. Cardiovascular Magnetic Resonance (CMR) vs. Echocardiography (historical/standard) was evaluated. Multi-parametric cardiovascular magnetic resonance imaging provides reproducible assessment of cardiac structure, function, and tissue characterization, playing an increasingly important role in the diagnosis and surveillance of cancer treatment-related cardiotoxicity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: